-Live Mint Almost two decades after the Panchayati Raj Act was notified, a key aim of the legislation remains unfulfilled Papapatti/Madurai district: S. Muruganadam, 38, is the Dalit president of the Papapatti village panchayat in Madurai district and a post-graduate in political science. His term ends in 2016 and he has made up his mind not to run for re-election. "I think a panchayat president's post is an important post because only he...

-Live Mint Lack of decentralization means municipalities lack power, resources to meet rising aspirations of ‘middle' India Othakadai, Madurai (Tamil Nadu)/Hubli (Karnataka): S. Paramasivam , president of the Othakadai panchayat, has big plans for his area. "Rainwater harvesting, removal of encroachments on roads, waste recycling, covered drainage, bigger primary health care centres and community parks," lists the 58-year-old, who has spent 30 years in the stainless steel business that dominates industry...

KEY TRENDS   • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8   • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...

-The Hindu The Supreme Court judgment on Glivec is a blow for a patent regime with a higher threshold of inventiveness On April 1, 2013, the Supreme Court upheld the Intellectual Property Appellate Board's decision to deny patent protection to Novartis's application covering a beta crystalline form of imatinib -the medicine Novartis brands as Glivec, and which is very effective against the form of cancer known as chronic myeloid leukaemia (CML). The...

-The Hindu Well before the Supreme Court rejected Novartis' application for patent for Glivec (Gleevec in the U.S.), drawing attention to the dichotomy of generic and patented drugs, activists have been demanding access to expensive drugs used in the treatment of cancer, hepatitis C and serious HIV. Trastuzumab is one such, used in the treatment of HER2+ type of breast cancer, which affects about one in four patients with the disease. Rough...